Literature DB >> 17472963

Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain.

Robert V Stahelin1, Preeti Subramanian, Mohsin Vora, Wonhwa Cho, Charles E Chalfant.   

Abstract

Previously, ceramide-1-phosphate (C1P) was demonstrated to be a potent and specific activator of group IV cytosolic phospholipase A(2)alpha (cPLA(2)alpha) via interaction with the C2 domain. In this study, we hypothesized that the specific interaction site for C1P was localized to the cationic beta-groove (Arg(57), Lys(58), Arg(59)) of the C2 domain of cPLA(2)alpha. In this regard, mutants of this region of cPLA(2)alpha were generated (R57A/K58A/R59A, R57A/R59A, K58A/R59A, R57A/K58A, R57A, K58A, and R59A) and examined for C1P affinity by surface plasmon resonance. The triple mutants (R57A/K58A/R59A), the double mutants (R57A/R59A, K58A/R59A, and R57A/K58A), and the single mutant (R59A) demonstrated significantly reduced affinity for C1P-containing vesicles as compared with wild-type cPLA(2)alpha. Examining these mutants for enzymatic activity demonstrated that these five mutants of cPLA(2)alpha also showed a significant reduction in the ability of C1P to: 1) increase the V(max) of the reaction; and 2) significantly decrease the dissociation constant (K (A)(s)) of the reaction as compared with the wild-type enzyme. The mutational effect was specific for C1P as all of the cationic mutants of cPLA(2)alpha demonstrated normal basal activity as well as normal affinities for phosphatidylcholine and phosphatidylinositol-4,5-bisphosphate as compared with wild-type cPLA(2)alpha. This study, for the first time, demonstrates a novel C1P interaction site mapped to the cationic beta-groove of the C2 domain of cPLA(2)alpha.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472963     DOI: 10.1074/jbc.M701396200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Lipid targeting domain with dual-membrane specificity that expands the diversity of intracellular targeting reactions.

Authors:  Joseph J Falke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-26       Impact factor: 11.205

Review 2.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

3.  Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression.

Authors:  Jody L Hankins; Todd E Fox; Brian M Barth; Kellee A Unrath; Mark Kester
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

5.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

6.  JNK and ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2.

Authors:  Albert Gubern; Miquel Barceló-Torns; David Barneda; José M López; Roser Masgrau; Fernando Picatoste; Charles E Chalfant; Jesús Balsinde; María A Balboa; Enrique Claro
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

7.  Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Authors:  Dayanjan S Wijesinghe; Preeti Subramanian; Nadia F Lamour; Luciana B Gentile; Maria H Granado; Alicja Bielawska; Zdzislaw Szulc; Antonio Gomez-Munoz; Charles E Chalfant
Journal:  J Lipid Res       Date:  2008-12-15       Impact factor: 5.922

Review 8.  Cellular and molecular interactions of phosphoinositides and peripheral proteins.

Authors:  Robert V Stahelin; Jordan L Scott; Cary T Frick
Journal:  Chem Phys Lipids       Date:  2014-02-17       Impact factor: 3.329

9.  Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin.

Authors:  Hiroyuki Nakamura; Shigeo Wakita; Akiko Suganami; Yutaka Tamura; Kentaro Hanada; Toshihiko Murayama
Journal:  J Lipid Res       Date:  2009-10-16       Impact factor: 5.922

10.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.